메뉴 건너뛰기




Volumn 15, Issue 5, 2016, Pages 705-714

Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease

Author keywords

Adipokine; Cytokine; Insulin resistance; Nonalcoholic steatohepatitis; Steatosis

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 6; RESISTIN; RETINOL BINDING PROTEIN 4; VASPIN; BIOLOGICAL MARKER; IL1A PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN; RETN PROTEIN, HUMAN; SERINE PROTEINASE INHIBITOR; SERPINA12 PROTEIN, HUMAN;

EID: 84982889638     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.5604/16652681.1212429     Document Type: Article
Times cited : (30)

References (54)
  • 1
    • 61349140201 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: The pathogenetic roles of insulin resistance and adipocytokines
    • Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 2009; 72: 299-314.
    • (2009) Curr Mol Med , vol.72 , pp. 299-314
    • Polyzos, S.A.1    Kountouras, J.2    Zavos, C.3
  • 3
    • 84951832157 scopus 로고    scopus 로고
    • Adipokines in nonalcoholic fatty liver disease
    • Polyzos SA, Kountouras J, Mantzoros CS. Adipokines in nonalcoholic fatty liver disease. Metabolism 2016; 10.1016/ j.metabol.2015.11.006.
    • (2015) Metabolism , vol.2016
    • Polyzos, S.A.1    Kountouras, J.2    Mantzoros, C.S.3
  • 4
    • 79951810722 scopus 로고    scopus 로고
    • Serum total adiponectin in nonalcoholic fatty liver disease: A systematic review and meta-analysis
    • Polyzos SA, Toulis KA, Goulis DG, Zavos C, Kountouras J. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Metabolism 2011; 60: 313-26.
    • (2011) Metabolism , vol.60 , pp. 313-326
    • Polyzos, S.A.1    Toulis, K.A.2    Goulis, D.G.3    Zavos, C.4    Kountouras, J.5
  • 5
    • 84923597485 scopus 로고    scopus 로고
    • Leptin in nonalcoholic fatty liver disease: A narrative review
    • Polyzos SA, Kountouras J, Mantzoros CS. Leptin in nonalcoholic fatty liver disease: A narrative review. Metabolism 2015; 64: 60-78.
    • (2015) Metabolism , vol.64 , pp. 60-78
    • Polyzos, S.A.1    Kountouras, J.2    Mantzoros, C.S.3
  • 9
    • 84922334179 scopus 로고    scopus 로고
    • Role of adipokines and cytokines in non-alcoholic fatty liver disease
    • Abenavoli L, Peta V. Role of adipokines and cytokines in non-alcoholic fatty liver disease. Rev Recent Clin Trials 2014; 9: 134-40.
    • (2014) Rev Recent Clin Trials , vol.9 , pp. 134-140
    • Abenavoli, L.1    Peta, V.2
  • 10
    • 84885737214 scopus 로고    scopus 로고
    • Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease
    • Genc H, Dogru T, Kara M, Tapan S, Ercin CN, Acikel C, Karslioglou Y, et al. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease. Ann Hepatol 2013; 12: 308-87.
    • (2013) Ann Hepatol , vol.12 , pp. 308-387
    • Genc, H.1    Dogru, T.2    Kara, M.3    Tapan, S.4    Ercin, C.N.5    Acikel, C.6    Karslioglou, Y.7
  • 11
    • 84878831361 scopus 로고    scopus 로고
    • Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease
    • Das SK, Balakrishnan V. Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease. Indian J Clin Biochem 2011; 26: 202-9.
    • (2011) Indian J Clin Biochem , vol.26 , pp. 202-209
    • Das, S.K.1    Balakrishnan, V.2
  • 14
    • 84862314680 scopus 로고    scopus 로고
    • Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
    • Coulon S, Francque S, Colle I, Verrijken A, Blomme B, Heindryckx F, De Munter S, et al. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. Cytokine 2012; 59: 442-9.
    • (2012) Cytokine , vol.59 , pp. 442-449
    • Coulon, S.1    Francque, S.2    Colle, I.3    Verrijken, A.4    Blomme, B.5    Heindryckx, F.6    De Munter, S.7
  • 17
    • 33646014467 scopus 로고    scopus 로고
    • Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis
    • Abiru S, Migita K, Maeda Y, Daikoku M, Ito M, Ohata K, Nagaoka S, et al. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int 2006; 26: 39-45.
    • (2006) Liver Int , vol.26 , pp. 39-45
    • Abiru, S.1    Migita, K.2    Maeda, Y.3    Daikoku, M.4    Ito, M.5    Ohata, K.6    Nagaoka, S.7
  • 19
    • 70449730945 scopus 로고    scopus 로고
    • Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease
    • Lemoine M, Ratziu V, Kim M, Maachi M, Wendum D, Paye F, Bastard JP, et al. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. Liver Int 2009; 29: 1431-8.
    • (2009) Liver Int , vol.29 , pp. 1431-1438
    • Lemoine, M.1    Ratziu, V.2    Kim, M.3    Maachi, M.4    Wendum, D.5    Paye, F.6    Bastard, J.P.7
  • 20
    • 84867819406 scopus 로고    scopus 로고
    • A novel pathophysiological-based panel of biomarkers for the diagnosis of nonalcoholic steatohepatitis
    • Grigorescu M, Crisan D, Radu C, Grigorescu MD, Sparchez Z, Serban A. A novel pathophysiological-based panel of biomarkers for the diagnosis of nonalcoholic steatohepatitis. J Physiol Pharmacol 2012; 63: 347-53.
    • (2012) J Physiol Pharmacol , vol.63 , pp. 347-353
    • Grigorescu, M.1    Crisan, D.2    Radu, C.3    Grigorescu, M.D.4    Sparchez, Z.5    Serban, A.6
  • 21
    • 34249824615 scopus 로고    scopus 로고
    • IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients
    • Garcia-Galiano D, Sanchez-Garrido MA, Espejo I, Montero JL, Costan G, Marchal T, Membrives A, et al. IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients. Obes Surg 2007; 17: 493-503.
    • (2007) Obes Surg , vol.17 , pp. 493-503
    • Garcia-Galiano, D.1    Sanchez-Garrido, M.A.2    Espejo, I.3    Montero, J.L.4    Costan, G.5    Marchal, T.6    Membrives, A.7
  • 23
    • 77953971188 scopus 로고    scopus 로고
    • Disease progression of non-alcoholic fatty liver disease: A prospective study with paired liver biopsies at 3 years
    • Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, et al. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-74.
    • (2010) Gut , vol.59 , pp. 969-974
    • Wong, V.W.1    Wong, G.L.2    Choi, P.C.3    Chan, A.W.4    Li, M.K.5    Chan, H.Y.6    Chim, A.M.7
  • 24
    • 84862690761 scopus 로고    scopus 로고
    • Vaspin in obesity and diabetes: Pathophysiological and clinical significance
    • Bluher M. Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 2012; 41: 176-82.
    • (2012) Endocrine , vol.41 , pp. 176-182
    • Bluher, M.1
  • 25
    • 79952988824 scopus 로고    scopus 로고
    • Serum levels of vaspin, obestatin, and apelin36 in patients with nonalcoholic fatty liver disease
    • Aktas B, Yilmaz Y, Eren F, Yonal O, Kurt R, Alahdab YO, Celikel CA, et al. Serum levels of vaspin, obestatin, and apelin36 in patients with nonalcoholic fatty liver disease. Metabolism 2011; 60: 544-9.
    • (2011) Metabolism , vol.60 , pp. 544-549
    • Aktas, B.1    Yilmaz, Y.2    Eren, F.3    Yonal, O.4    Kurt, R.5    Alahdab, Y.O.6    Celikel, C.A.7
  • 26
    • 79960212414 scopus 로고    scopus 로고
    • Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease
    • Yilmaz Y, Kurt R, Gurdal A, Alahdab YO, Yonal O, Senates E, Polat N, et al. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 2011; 217: 125-9.
    • (2011) Atherosclerosis , vol.217 , pp. 125-129
    • Yilmaz, Y.1    Kurt, R.2    Gurdal, A.3    Alahdab, Y.O.4    Yonal, O.5    Senates, E.6    Polat, N.7
  • 27
    • 80054088904 scopus 로고    scopus 로고
    • Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis
    • Genc H, Dogru T, Tapan S, Kara M, Ercin CN, Aslan F, Kantarcioglu M, et al. Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis. Scand J Gastroenterol 2011; 46: 1355-61.
    • (2011) Scand J Gastroenterol , vol.46 , pp. 1355-1361
    • Genc, H.1    Dogru, T.2    Tapan, S.3    Kara, M.4    Ercin, C.N.5    Aslan, F.6    Kantarcioglu, M.7
  • 29
    • 33644826101 scopus 로고    scopus 로고
    • Macrophages in human visceral adipose tissue: Increased accumulation in obesity and a source of resistin and visfatin
    • Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, Bouloumie A. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006; 49: 744-7.
    • (2006) Diabetologia , vol.49 , pp. 744-747
    • Curat, C.A.1    Wegner, V.2    Sengenes, C.3    Miranville, A.4    Tonus, C.5    Busse, R.6    Bouloumie, A.7
  • 30
    • 0035487109 scopus 로고    scopus 로고
    • Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans
    • Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O’Rahilly S. Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001; 50: 2199-202.
    • (2001) Diabetes , vol.50 , pp. 2199-2202
    • Savage, D.B.1    Sewter, C.P.2    Klenk, E.S.3    Segal, D.G.4    Vidal-Puig, A.5    Considine, R.V.6    O’Rahilly, S.7
  • 31
    • 33644825288 scopus 로고    scopus 로고
    • Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance
    • Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, Donnini D, et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab 2006; 91: 1081-6.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 1081-1086
    • Pagano, C.1    Soardo, G.2    Pilon, C.3    Milocco, C.4    Basan, L.5    Milan, G.6    Donnini, D.7
  • 32
    • 84871744951 scopus 로고    scopus 로고
    • Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores
    • Senates E, Colak Y, Yesil A, Coskunpinar E, Sahin O, Kahraman OT, Erkalma Senates B, et al. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. Minerva Med 2012; 103: 369-76.
    • (2012) Minerva Med , vol.103 , pp. 369-376
    • Senates, E.1    Colak, Y.2    Yesil, A.3    Coskunpinar, E.4    Sahin, O.5    Kahraman, O.T.6    Erkalma Senates, B.7
  • 33
    • 77954002114 scopus 로고    scopus 로고
    • Serum retinolbinding protein 4 in patients with nonalcoholic fatty liver disease: Does it have a significant impact on pathogenesis?
    • Cengiz C, Ardicoglu Y, Bulut S, Boyacioglu S. Serum retinolbinding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis? Eur J Gastroenterol Hepatol 2010; 22: 813-9.
    • (2010) Eur J Gastroenterol Hepatol , vol.22 , pp. 813-819
    • Cengiz, C.1    Ardicoglu, Y.2    Bulut, S.3    Boyacioglu, S.4
  • 34
    • 84895447781 scopus 로고    scopus 로고
    • The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis
    • Shen C, Zhao CY, Wang W, Wang YD, Sun H, Cao W, Yu WY, et al. The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis. BMC Gastroenterol 2014; 14: 39.
    • (2014) BMC Gastroenterol , vol.14 , pp. 39
    • Shen, C.1    Zhao, C.Y.2    Wang, W.3    Wang, Y.D.4    Sun, H.5    Cao, W.6    Yu, W.Y.7
  • 38
    • 84855554342 scopus 로고    scopus 로고
    • Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: An endocrine signature for advanced fibrosis in obese patients
    • Koehler E, Swain J, Sanderson S, Krishnan A, Watt K, Charlton M. Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients. Liver Int 2012; 32: 279-86.
    • (2012) Liver Int , vol.32 , pp. 279-286
    • Koehler, E.1    Swain, J.2    Sanderson, S.3    Krishnan, A.4    Watt, K.5    Charlton, M.6
  • 39
    • 30944469306 scopus 로고    scopus 로고
    • Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease
    • Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Faga E, Pacini G, et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005; 42: 1175-83.
    • (2005) Hepatology , vol.42 , pp. 1175-1183
    • Musso, G.1    Gambino, R.2    Durazzo, M.3    Biroli, G.4    Carello, M.5    Faga, E.6    Pacini, G.7
  • 42
    • 84908222061 scopus 로고    scopus 로고
    • Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease
    • Abenavoli L, Luigiano C, Guzzi PH, Milic N, Morace C, Stelitano L, Consolo P, et al. Serum adipokine levels in overweight patients and their relationship with non-alcoholic fatty liver disease. Panminerva Med 2014; 56: 189-93.
    • (2014) Panminerva Med , vol.56 , pp. 189-193
    • Abenavoli, L.1    Luigiano, C.2    Guzzi, P.H.3    Milic, N.4    Morace, C.5    Stelitano, L.6    Consolo, P.7
  • 43
    • 34347233419 scopus 로고    scopus 로고
    • Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass
    • Kloting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, Fasshauer M, et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007; 6: 79-87.
    • (2007) Cell Metab , vol.6 , pp. 79-87
    • Kloting, N.1    Graham, T.E.2    Berndt, J.3    Kralisch, S.4    Kovacs, P.5    Wason, C.J.6    Fasshauer, M.7
  • 44
    • 0024445843 scopus 로고
    • Retinol-binding protein: The serum transport protein for vitamin A
    • Blaner WS. Retinol-binding protein: the serum transport protein for vitamin A. Endocr Rev 1989; 10: 308-16.
    • (1989) Endocr Rev , vol.10 , pp. 308-316
    • Blaner, W.S.1
  • 45
    • 84876296264 scopus 로고    scopus 로고
    • Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. Histologically normal liver from morbidly obese women
    • Terra X, Auguet T, Broch M, Sabench F, Hernandez M, Pastor RM, Quesada IM, et al. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women. Obesity 2013; 21: 170-7.
    • (2013) Obesity , vol.21 , pp. 170-177
    • Terra, X.1    Auguet, T.2    Broch, M.3    Sabench, F.4    Hernandez, M.5    Pastor, R.M.6    Quesada, I.M.7
  • 46
    • 68949111875 scopus 로고    scopus 로고
    • Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease
    • Milner KL, van der Poorten D, Xu A, Bugianesi E, Kench JG, Lam KS, Chisholm DJ, et al. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease. Hepatology 2009; 49: 1926-34.
    • (2009) Hepatology , vol.49 , pp. 1926-1934
    • Milner, K.L.1    Van Der Poorten, D.2    Xu, A.3    Bugianesi, E.4    Kench, J.G.5    Lam, K.S.6    Chisholm, D.J.7
  • 47
    • 69749093721 scopus 로고    scopus 로고
    • Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort
    • Kashyap SR, Diab DL, Baker AR, Yerian L, Bajaj H, GrayMcGuire C, Schauer PR, et al. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. Obesity 2009; 17: 1696-701.
    • (2009) Obesity , vol.17 , pp. 1696-1701
    • Kashyap, S.R.1    Diab, D.L.2    Baker, A.R.3    Yerian, L.4    Bajaj, H.5    Graymcguire, C.6    Schauer, P.R.7
  • 49
    • 74949109369 scopus 로고    scopus 로고
    • Serum retinolbinding protein 4 levels in patients with nonalcoholic fatty liver disease
    • Alkhouri N, Lopez R, Berk M, Feldstein AE. Serum retinolbinding protein 4 levels in patients with nonalcoholic fatty liver disease. J Clin Gastroenterol 2009; 43: 985-9.
    • (2009) J Clin Gastroenterol , vol.43 , pp. 985-989
    • Alkhouri, N.1    Lopez, R.2    Berk, M.3    Feldstein, A.E.4
  • 50
    • 67349256422 scopus 로고    scopus 로고
    • Retinol-binding protein 4: A promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease
    • Nobili V, Alkhouri N, Alisi A, Ottino S, Lopez R, Manco M, Feldstein AE. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009; 7: 575-9.
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 575-579
    • Nobili, V.1    Alkhouri, N.2    Alisi, A.3    Ottino, S.4    Lopez, R.5    Manco, M.6    Feldstein, A.E.7
  • 52
    • 33646479192 scopus 로고    scopus 로고
    • Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease
    • Poniachik J, Csendes A, Diaz JC, Rojas J, Burdiles P, Maluenda F, Smok G, et al. Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine 2006; 33: 252-7.
    • (2006) Cytokine , vol.33 , pp. 252-257
    • Poniachik, J.1    Csendes, A.2    Diaz, J.C.3    Rojas, J.4    Burdiles, P.5    Maluenda, F.6    Smok, G.7
  • 53
    • 80054737370 scopus 로고    scopus 로고
    • Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice
    • Kamari Y, Shaish A, Vax E, Shemesh S, Kandel-Kfir M, Arbel Y, Olteanu S, et al. Lack of interleukin-1alpha or interleukin-1beta inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol 2011; 55: 1086-94.
    • (2011) J Hepatol , vol.55 , pp. 1086-1094
    • Kamari, Y.1    Shaish, A.2    Vax, E.3    Shemesh, S.4    Kandel-Kfir, M.5    Arbel, Y.6    Olteanu, S.7
  • 54
    • 84858842467 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease: Multimodal treatment options for a pathogenetically multiple-hit disease
    • Polyzos SA, Kountouras J, Zavos C, Deretzi G. Nonalcoholic fatty liver disease: Multimodal treatment options for a pathogenetically multiple-hit disease. J Clin Gastroenterol 2012; 46: 272-84.
    • (2012) J Clin Gastroenterol , vol.46 , pp. 272-284
    • Polyzos, S.A.1    Kountouras, J.2    Zavos, C.3    Deretzi, G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.